Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 3.250% 7/0
-
Market price (% of par)
-
94.68%
-
Total 13F principal
-
$82,778,227
-
Principal change
-
-$331,915
-
Total reported market value
-
$79,161,051
-
Number of holders
-
24
-
Value change
-
-$6,465
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 as of Q4 2021
As of 31 Dec 2021,
INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$82,778,227
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), OAKTREE CAPITAL MANAGEMENT LP, MORGAN STANLEY, Kohlberg Kravis Roberts & Co. L.P., BlackRock Inc., Saltoro Capital, LP, STATE STREET CORP, Russell Investments Group, Ltd., Parallax Volatility Advisers, L.P., and L & S Advisors Inc.
This page lists
24
institutional bondholders reporting positions
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.